TCA
Trifecta Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2
| Closed | -$1.27K | – | 499 |
|
|
2025
Q1 | $1.27K | Sell |
2
-122
| -98% | -$77.4K | ﹤0.01% | 353 |
|
|
2024
Q4 | $88.3K | Sell |
124
-3,570
| -97% | -$2.54M | 0.02% | 111 |
|
|
2024
Q3 | $3.88M | Buy |
3,694
+111
| +3% | +$117K | 0.81% | 40 |
|
|
2024
Q2 | $3.77M | Buy |
3,583
+285
| +9% | +$300K | 0.83% | 36 |
|
|
2024
Q1 | $3.17M | Buy |
3,298
+765
| +30% | +$736K | 0.77% | 39 |
|
|
2023
Q4 | $2.22M | Buy |
2,533
+2,465
| +3,625% | +$2.16M | 0.62% | 46 |
|
|
2023
Q3 | $56K | Sell |
68
-10
| -13% | -$8.23K | 0.02% | 133 |
|
|
2023
Q2 | $56K | Buy |
78
+5
| +7% | +$3.59K | 0.02% | 136 |
|
|
2023
Q1 | $60K | Buy |
73
+15
| +26% | +$12.3K | 0.02% | 132 |
|
|
2022
Q4 | $41.8K | Buy |
+58
| New | +$41.8K | 0.02% | 133 |
|